PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
67.63
+4.81 (7.65%)
Mar 9, 2026, 1:56 PM EDT - Market open
PTC Therapeutics Market Cap
PTC Therapeutics has a market cap or net worth of $5.60 billion as of March 9, 2026. Its market cap has increased by 44.06% in one year.
Market Cap
5.60B
Enterprise Value
6.30B
1-Year Change
44.06%
Ranking
Category
Stock Price
$67.63
Market Cap Chart
Since June 20, 2013, PTC Therapeutics's market cap has increased from $366.20M to $5.60B, an increase of 1,428.57%. That is a compound annual growth rate of 23.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 5.20B | -14.74% |
| Dec 31, 2025 | 6.10B | 75.18% |
| Dec 31, 2024 | 3.48B | 67.39% |
| Dec 29, 2023 | 2.08B | -24.20% |
| Dec 30, 2022 | 2.74B | -2.56% |
| Dec 31, 2021 | 2.82B | -32.38% |
| Dec 31, 2020 | 4.16B | 40.68% |
| Dec 31, 2019 | 2.96B | 70.95% |
| Dec 31, 2018 | 1.73B | 150.23% |
| Dec 29, 2017 | 692.00M | 84.83% |
| Dec 30, 2016 | 374.40M | -66.28% |
| Dec 31, 2015 | 1.11B | -36.17% |
| Dec 31, 2014 | 1.74B | 311.45% |
| Dec 31, 2013 | 422.80M | 15.46% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Protagonist Therapeutics | 5.88B |
| Immunovant | 5.43B |
| CRISPR Therapeutics AG | 5.42B |
| Celcuity | 5.32B |
| Caris Life Sciences | 5.25B |
| CG Oncology | 5.22B |
| Mirum Pharmaceuticals | 5.21B |
| Scholar Rock Holding | 5.20B |